A novel small-molecule antagonizes PRMT5-mediated KLF4 methylation for targeted therapy. [electronic resource]
- EBioMedicine Jun 2019
- 98-111 p. digital
Publication Type: Journal Article
2352-3964
10.1016/j.ebiom.2019.05.011 doi
Animals Antineoplastic Agents--pharmacology Cell Line Cell Line, Tumor Cell Survival--drug effects DNA Damage DNA Methylation--drug effects Dose-Response Relationship, Drug Drug Discovery Enzyme Inhibitors--chemistry Epigenesis, Genetic--drug effects Female Gene Expression Regulation, Neoplastic--drug effects Humans Immunohistochemistry Kruppel-Like Factor 4 Kruppel-Like Transcription Factors--genetics Mice Models, Molecular Molecular Conformation Molecular Targeted Therapy Neoplastic Stem Cells--metabolism Protein-Arginine N-Methyltransferases--antagonists & inhibitors Recombinant Fusion Proteins Structure-Activity Relationship Substrate Specificity Triple Negative Breast Neoplasms--genetics Xenograft Model Antitumor Assays